20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING A GROWTH RELATED DISEASE AND/OR A CLINICAL CONDITION THEREOF
#5702METHOD FOR TREATMENT OF TRAUMATIC BRAIN INJURIES
#5703ONCOLYTIC VACCINIA VIRUS CANCER THERAPY
#5704AAV VECTOR FOR TREATMENT OF FRIEDREICH'S ATAXIA
#5705Animal protein-free pharmaceutical compositions
#5706LIQUID PHARMACEUTICAL COMPOSITION
#5707Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3
#5708Compositions for use to treat advanced glycation end products-dependent ocular diseases
#5709PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF
#5710BIODEGRADABLE DRUG DELIVERY COMPOSITION
#5711GENOTYPE-DIRECTED LOCAL DELIVERY OF TARGETED THERAPEUTICS
#5712METHOD OF TREATING AND PREVENTING CORONAVIRUS DISEASE 19 (COVID-19) USING A SELENIUM ADMINISTRATION
#5713METHOD FOR ACCELERATED TISSUE PENETRATION OF COMPOUNDS INTO BRAIN
#5714INJECTABLE MONOPHASE HYDROGELS
#5715DNA ORIGAMI NANOSTRUCTURES FOR TREATMENT OF ACUTE KIDNEY INJURY
#5716Methods of reducing risk of preterm birth
#5717NOVEL METHODS
#5718Antiviral prodrugs and nanoformulations thereof
#5719Fused heterotricyclic organic compounds, pharmaceutical compositions, and medical uses thereof
#5720Use of Trimetazidine in Preparation of Drugs for Preventing and Treating Liver Diseases
#5721Methods of treating epithelioid cell tumors
#5722METHODS AND COMPOSITIONS FOR TREATING SEPSIS
#5723Method of Treatment for Ketamine Infusion
#5724Compositions and Methods for the Treatment of Metabolic Conditions
#5725COMBINATION THERAPY OF COENZYME Q10 AND RADIATION FOR TREATMENT OF GLIOMA
#5726NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT
#5727EXTRACELLULAR VESICLES COMPRISING STING-AGONIST
#5728ZINC MELOXICAM COMPLEX MICROPARTICLES AND ANESTHETIC FORMULATIONS AND PROCESSES FOR MAKING THE SAME
#5729DOSING REGIMENS FOR TREATING METAL-MEDIATED CONDITIONS
#5730COLD SOLUTION FOR FAT REDUCTION
#5731Means and method for producing and purifying viral vectors
#5732OLIGONUCLEOTIDE COMPOSITIONS FOR TARGETING CCR2 AND CSF1R AND USES THEREOF
#5733GENE EDITING OF ANTICOAGULANTS
#5734COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND TREATING VIRAL INFECTIONS
#5735Analogs of 2-pralidoxime as antidotes against organophosphorus nerve agents
#5736BOTULINUM TOXIN PREFILLED CONTAINER
#5737COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND TREATING VIRAL INFECTIONS
#5738TRACE ELEMENT SOLUTION
#5739Methods of using buffered formulations of exendin (9-39)
#5740Photodynamic therapy comprising two light exposures at different wavelengths
#5741COMBINATION INCLUDING A CPG-C TYPE OLIGONUCLEOTIDE AND A PD-1 ANTAGONIST FOR TREATING BREAST CANCER
#5742METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A
#5743FORMULATIONS FOR IMPROVED STABILITY OF RECOMBINANT HUMAN PARATHYROID HORMONE
#5744THERMOSTABLE FORMULATION OF A21G HUMAN INSULIN
#5745METHOD FOR PREVENTION OR TREATMENT OF OBESITY, REDUCING BODY WEIGHT AND/OR FOOD INTAKE, OR INDUCING SATIETY IN A SUBJECT
#5746Treatment of post-bariatric hypoglycemia with exendin (9-39)
#5747STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS
#5748Compositions comprising a bacterial strain of the genus and uses thereof
#5749METHODS OF TREATING INFLAMMATION
#5750Compositions and methods for degenerative disc regeneration
#5751Treatment of glaucoma
#5752Compounds and Methods for Modulation of Transcript Processing
#5753Basic chemotherapeutic intratumour injection formulation
#5754SELF-ASSEMBLED GELS FORMED WITH ANTI-RETROVIRAL DRUGS, PRODRUGS THEREOF, AND PHARMACEUTICAL USES THEREOF
#5755LPXC INHIBITOR, FORMULATIONS, AND USES THEREOF
#5756Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
#5757METHODS OF TREATING VIRAL INFECTIONS USING INHIBITORS OF NUCLEOTIDE SYNTHESIS PATHWAYS
#5758TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES
#5759CAPSAICIN SEQUENTIAL DOSING METHOD FOR TREATMENT OF KNEE JOINT PAIN
#5760Allosteric enhancing compound of GABAA receptor and preparation and use thereof
#5761Injectable composition including hyaluronic acid and use of the said composition
#5762SUSTAINED-RELEASE INJECTABLE ANTIBIOTICAL FORMULATION
#5763SYSTEM AND METHOD FOR A HEALTH STATUS DISPLAY BASED ON DETECTED MAGNETIC NANOPARTICLES
#5764Antisense oligomers for treatment of conditions and diseases
#5765TREATMENT OF MOST BOTHERSOME SYMPTOM (MBS) ASSOCIATED WITH MIGRAINE USING ANTI-CGRP ANTIBODIES
#5766Arginine-free TNFR:FC-fusion polypeptide compositions
#5767Ultra-long acting insulin-Fc fusion proteins
#5768GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#5769MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS
#5770Compound having TrkA inhibitory activity and pharmaceutical composition, for preventing or alleviating pain, containing same as active ingredient
#5771SYRINGE AND KIT FOR INTRAVESICAL USE
#5772LIPOFULLERENE CONJUGATES AND THEIR USE FOR PROMOTION OF HAIR GROWTH AND PREVENTION OF HAIR LOSS
#5773LIQUID PHARMACEUTICAL COMPOSITION
#5774Hydroxyapatite powder and process for producing same, composition based on this powder and process for preparing same and kit comprising this powder
#5775INJECTION SOLUTION FOR RNA
#5776Recombinant L-asparaginase
#5777BOTULINUM TOXIN AND THE TREATMENT OF PRIMARY DISORDERS OF MOOD AND AFFECT
#5778CONTROLLED RELEASE PEPTIDE FORMULATIONS
#5779Long-Acting Formulations of Insulin
#5780GALECTIN-1 IMMUNOMODULATION AND MYOGENIC IMPROVEMENTS IN MUSCLE DISEASES AND AUTOIMMUNE DISORDERS
#5781Macrocyclic peptides to decrease c-Myc protein levels and reduce cancer cell growth
#5782Method of treating eye diseases with krill oil
#5783COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC ENTERITIS CONTAINING DNA FRAGMENT MIXTURE ISOLATED FROM SPERM OR TESTIS OF FISH
#5784Drug Used for Treating Tissue Necrosis or for Improving Cardiac Function
#5785HUMAN UMBILICAL CORD BLOOD MESENCHYMAL STEM CELL TRANSFUSION IMMUNOTHERAPY FOR TREATMENT OF CYTOKINE STORM ASSOCIATED WITH CORONAVIRUS INFECTION
#5786Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates
#5787Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
#5788USE OF ANDROGENS FOR TREATING CORONA VIRUS
#5789COMPOSITIONS AND METHODS FOR REDUCING BODY FAT
#5790Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
#5791Dosage form of vinca alkaloid drug
#5792TASK-1 INHIBITORS FOR TREATMENT OF ATRIAL ARRHYTHMIAS
#5793METHODS AND COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
#5794Method and Composition for Enhancing the Quality and Benefits of Sleep
#5795NEW USE OF INHIBITORS OF MONOAMINE OXIDASE TYPE B
#5796COMPOSITIONS COMPRISING PROPOFOL, KETAMINE, AND ANALGESIC, AND METHODS OF USE
#5797Hyaluronate compositions and soft tissue fillers
#5798Sustained-release compositions comprising a therapeutic agent for treating depression or anxiety and uses thereof
#5799Sustained-release pharmaceutical compositions comprising an antipsychotic drug and uses thereof
#5800Ocular implant containing a tyrosine kinase inhibitor
#5801Injectable buprenorphine formulation
#5802Devices and systems for ablation therapy
#5803GENE THERAPY METHODS TO CONTROL ORGAN FUNCTION
#5804GLUCOCEREBROSIDASE GENE THERAPY
#5805Methods for treating atopic dermatitis and related disorders
#5806A PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OR PREVENTION OF A C5-RELATED DISEASE AND A METHOD FOR TREATING OR PREVENTING A C5-RELATED DISEASE
#5807ANTI-HSPA5 ANTIBODIES AND USES THEREOF
#5808STABLE POLYMORPHIC COMPOSITIONS OF BREQUINAR SODIUM AND METHODS OF USE AND MANUFACTURE THEREOF
#5809Lipid nanoparticle compositions and methods for mRNA delivery
#5810METHODS OF EXPLOITING ONCOGENIC DRIVERS ALONG THE HUMAN CYCLIN G1 PATHWAY FOR CANCER GENE THERAPY
#5811Composition and method for dual targeting in treatment of neuroendocrine tumors
#5812Photodynamic compositions and methods of use
#5813COMPOSITIONS OF FCRN ANTIBODIES AND METHODS OF USE THEREOF
#5814Injection paradigm for administration of botulinum toxins
#5815Treatment of amyotrophic lateral sclerosis using botulinum toxin
#5816Polynucleotides encoding interleukin-12 (IL12) and uses thereof
#5817PEPTIDOMIMETIC MACROCYCLES AND FORMULATIONS THEREOF
#5818SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
#5819SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
#5820Systems, methods, and kits for diagnostics and treatment of viral respiratory infection
#5821METHODS AND SYSTEMS FOR PRODUCING AND ADMINISTERING ANTIVIRAL PLATELET THERAPY
#582217α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors
#5823USE OF PREGNENOLONE SULFATE TO REDUCE CYST FORMATION IN KIDNEY
#5824Methods for preventing and treating retinal damage
#5825EIF4A INHIBITOR COMBINATIONS
#5826EXTENDED RELEASE INJECTABLE FORMULATIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF
#5827Methods for treating Parkinson's disease by administering resiniferatoxin
#5828Method and composition for preventing and treating viral infections
#5829Methods for the treatment of inflammation associated with infection
#5830Methods and compositions for treatment of pain using capsaicin
#5831Methods of treatment for anorexia nervosa, bulimia and related clinical syndromes
#5832INJECTABLE PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR
#5833Process for preparing microparticles containing glatiramer acetate
#5834ZINC MELOXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND PROCESSES FOR MAKING THE SAME
#5835Pharmaceutical compositions for the treatment of ophthalmic conditions
#5836Solution and method for reducing the virulence of viruses, bacteria,yeasts, or fungus
#5837METHOD TO PREVENT AND TREAT OCULAR CATARACT BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#5838Method for enhancing gene expression using AAV vector
#5839Exosomes and miRNA to treat glaucoma
#5840High-concentration monoclonal antibody formulations
#5841METHODS FOR TREATMENT AND DIAGNOSIS OF CANCER BY TARGETING GLYCOPROTEIN A REPETITIONS PREDOMINANT (GARP) AND FOR PROVIDING EFFECTIVE IMMUNOTHERAPY ALONE OR IN COMBINATION
#5842T cell-antigen coupler with Y177 mutation and methods of uses thereof
#5843USE OF IL-1BETA BINDING ANTIBODY CANAKINUMAB FOR TREATING OR ALLEVATING SYMPTOMS PULMONARY SARCOIDOSIS
#5844PRE-FILLED SYRINGE AND METHOD OF PRODUCING PRE-FILLED SYRINGE
#5845KRAS mutant protein inhibitors
#58462-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof
#5847Treatment of osteoarthritis
#5848Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof
#5849ENGINEERED RECEPTOR/LIGAND SYSTEM FOR DELIVERY OF THERAPEUTIC AGENTS
#5850Complex coacervate for controlled release and related methods
#5851NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#5852INJECTABLE MICRONIZED HUMAN INSULIN
#5853GLP-1R and GCGR Agonists, Formulations, and Methods of Use
#5854Treatment of post-bariatric hypoglycemia with GLP-1 antagonists
#5855Therapeutic RNA
#5856METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#5857METHODS AND COMPOSITIONS FOR MODULATING MYELOID-DERIVED SUPPRESSOR CELLS
#5858METHOD OF USING ALLOGENEIC HAPLOIDENTICAL ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION IN THE TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME PATIENT
#5859Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant
#5860TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING
#5861MODULATION OF LNC05 EXPRESSION
#5862Sting agonists for treating bladder cancer and solid tumors
#5863COMPOUNDS AND METHODS FOR TREATING FUNGAL INFECTIONS
#5864IP and IP analogs dosage regimens for the treatment of ectopic calcifications
#5865Procaspase combination therapy for glioblastoma
#5866Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer
#5867METHOD TO PREVENT AND TREAT OSTEOARTHRITIS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#5868Compositions and methods for treating adult-onset neuronal ceroid lipofuscinosis (Kufs disease)
#5869Use of gTso thal in manufacturing medicament for promotion of MS-275 to cross blood-brain barrier
#5870METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH CORTICO-HIPPOCAMPAL HYPERACTIVITY
#5871Implantable drug delivery devices for localized drug delivery
#5872COMPOSITIONS AND METHODS FOR TREATING NEUROPSYCHIATRIC DISEASES
#5873METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN
#5874LIPOSOMAL ELINAFIDE FORMULATIONS AND USES THEREOF
#5875METHOD FOR THE PRODUCTION OF FREEZE-DRIED PELLETS COMPRISING AN ANTI-COAGULATION FACTOR XIa (FXIa) ANTIBODY
#5876FORMULATIONS OF ANTIBODY
#5877GENE THERAPY FOR TREATING FAMILIAL HYPERCHOLESTEROLEMIA
#5878LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
#5879PH20 polypeptide variants, formulations and uses thereof
#5880ANTI-PD-1 ANTIBODIES, OR FRAGMENTS THEREOF, FOR TREATING HEPATITIS B
#5881METHODS OF TREATING NEURODEGENERATIVE DISEASES
#5882Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders
#5883HYALURONIC ACID-BASED GELS INCLUDING LIDOCAINE
#5884PROTEIN FORMULATIONS
#5885DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS
#5886Compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody and an anti-PD-1 or anti-PD-L1 antibody
#5887COMBINATION THERAPY FOR CANCER WITH EXON 14 SKIPPING MUTATION(S) OR EXON 14 SKIPPING PHENOTYPE
#5888BOTULINUM TOXIN AND THE TREATMENT OF PRIMARY DISORDERS OF MOOD AND AFFECT
#5889METHODS AND COMPOSITIONS FOR TREATING CANINE CONDITIONS USING RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS
#5890Daptomycin formulations containing a combination of sorbitol and mannitol
#5891Hydrophilic antibody-drug conjugates
#5892Compositions and methods of treatment with amniotic fluid
#5893Engineered Exosomes for Medical Applications
#5894BIOACTIVE RENAL CELLS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE
#5895USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES
#5896Methods for treating hepatitis B infection
#5897Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
#5898MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS
#5899METHOTREXATE FOR PROLIFERATIVE VITREORETINOPATHY
#5900Methods of treatment
#5901Formulations of hydroxypyridonate actinide/lanthanide decorporation agents
#5902Methods of treating diseases associated with repeat instability
#5903Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof
#5904Pharmaceutical combinations for the treatment of cancer
#5905CDC7 kinase inhibitors and uses thereof
#5906Use of fumaric acid esters and pharmaceutically acceptable salts thereof in preparing pharmaceuticals for treating ferroptosis-related diseases
#5907PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF KIDNEY DAMAGE
#5908COMPOSITIONS FOR THERAPEUTICS PRESCREENING
#5909LIQUID FORMULATIONS OF GLUCAGON ANALOGUES
#5910INTRAVENOUS SOTALOL HYDROCHLORIDE LOADING AND MAINTENANCE FOR CARDIAC SURGERY PATIENTS
#5911BOTULINUM TOXIN CELL BINDING DOMAIN POLYPEPTIDES AND METHODS OF USE FOR TREATMENTS OF FIBROSIS ASSOCIATED DISORDERS
#5912PH20 polypeptide variants, formulations and uses thereof
#5913BCMA-CAR-natural killer (NK) cells and methods related thereto
#5914TREATING ULCERATIVE COLITIS WITH BRAZIKUMAB
#5915Anti-TNF antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
#5916Humanized anti-S100A9 antibody and uses thereof
#5917Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
#5918Activators of the unfolded protein response
#5919Prostacyclin compounds, compositions and methods of use thereof
#5920COVALENT ANESTHETIC-POLYMER CONJUGATES FOR PROLONGED LOCAL ANESTHESIA
#5921Compound usable as cationic lipid
#5922High concentration antibody formulations
#5923METHODS AND COMPOSITIONS FOR THE TREATMENT OF RADIATION-RELATED DISORDERS
#5924Mitochondrial augmentation therapy of ocular diseases
#5925ALS treatment using induced regulatory T (iTREG) cells
#5926MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR REGULATING INTRACELLULAR SIGNAL TRANSDUCTION
#5927Pharmaceutical composition for preventing or treating inflammatory diseases, containing nitrogen monoxide-sensitive acrylamide-based polymer
#5928ANTI-VIRUS AGENT AND METHOD FOR TREATMENT OF VIRAL INFECTION
#5929Highly active compounds against COVID-19
#5930CANCER TREATMENT METHODS
#5931Pharmaceutical compositions and methods of making pharmaceutical compositions comprising 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate
#5932Antiviral prodrugs and nanoformulations thereof
#5933Liquid bendamustine pharmaceutical compositions
#5934EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
#5935Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia
#5936Injectable suspension comprising an insoluble corticosteroid and a soluble corticosteroid
#5937METHODS, PARENTERAL PHARMACEUTICAL FORMULATIONS, AND DEVICES FOR THE PREVENTION OF OPIOID OVERDOSE
#5938SUSTAINED-RELEASE INJECTION PREPARATION CONTAINING DONEPEZIL DERIVATIVE
#5939VIRAL VECTOR FOR TREATING AUTOIMMUNE DISEASE AND DIABETES AND CONSTRUCTION METHOD AND APPLICATION THEREOF
#5940System and method for modulating stress granule assembly
#5941NEONATAL STROMAL CELLS HAVING LOW MHC-I EXPRESSION AND USES THEROF
#5942Anti-BAFFR antibody formulations and methods of use thereof
#5943Siderophore conjugated pyrazolidinones, and analogues thereof
#5944TREATING SPINAL CORD INJURY (SCI) AND BRAIN INJURY USING GSX1
#5945Methods of preparing a pegylated human IL-11 composition
#5946PEPTIDE SLOW-RELEASE FORMULATIONS
#5947Animal protein-free pharmaceutical compositions
#5948TATk-CDKL5 Fusion Proteins, Compositions, Formulations, and Use Thereof
#5949PHARMACEUTICAL COMPOSITION AND METHOD FOR NEOANGIOGENESIS/REVASCULARIZATION USEFUL IN TREATING ISCHEMIC HEART DISEASE
#5950METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES
#5951Pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
#5952COMBINATION OF A TYPE II PROTEIN ARGININE METHYLTRANSFERASE INHIBITOR AND AN ICOS BINDING PROTEIN TO TREAT CANCER
#5953METHODS FOR TREATING AGITATION USING DEXMEDETOMIDINE HYDROCHLORIDE
#5954Use of mitoxantrone liposome for treating non-Hodgkin's lymphoma
#5955MUCOADHESIVE LIPIDIC DELIVERY SYSTEM
#5956Therapeutic composition for intraperitoneal administration
#5957RECOMBINANT NUCLEIC ACID CONSTRUCT
#5958Combination therapy with liposomal antisense oligonucleotides
#5959Gene editing to improve joint function
#5960Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#5961Liquid Pharmaceutical Composition Comprising an Anti-IL-6 Receptor Antibody
#5962Compositions for treatment of disorders
#5963Antibodies recognizing tau
#5964COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE
#5965FCgammaRIIB-SPECIFIC FC REGION VARIANT
#5966Compstatin analogs with increased solubility and improved pharmacokinetic properties
#5967THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#5968A BIOLOGICALLY INERT FLUID FOR USE IN THE TREATMENT OF A CNS DISORDER
#5969POLYION COMPLEX CAPABLE OF EFFICIENTLY DELIVERING MRNA INTO LIVING BODY, AND DRUG AND METHOD FOR TREATING ARTHROPATHY IN WHICH SAID COMPLEX IS USED
#5970CONJUGATED LIPOMERS AND USES THEREOF
#5971Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
#5972Method of treating mucopolysaccharidosis type IVA
#5973Method for preventing or treating osteoporosis, characterized by administering teriparatide or salt thereof at a frequency of twice a week
#5974Methods and compositions for treatment of bone, skin, subcutaneous, mucosal and/or submucosal cancer by percutaneous and/or transmucosal administration of interferon
#5975FGF-21 formulations
#5976THERAPEUTIC COMPOSITION FOR ENDOMETRIOSIS SURGERY AND METHOD FOR USING THE SAME
#5977Therapy for polyglutamine (polyQ) diseases
#5978CRYOPRECIPITATE COMPOSITIONS AND METHODS OF PREPARATION THEREOF
#5979NOVEL METHODS FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS
#5980Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration
#5981Methods for therapeutic administration of messenger ribonucleic acid drugs
#5982Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
#5983FULVESTRANT FORMULATIONS
#5984SEIZURE CONTROL COMPOSITIONS AND METHODS OF USING SAME
#5985POZIOTINIB COMBINATIONS WITH AN ANTI-HER1, HER2 OR HER4 ANTIBODY AND METHODS OF USE THEREOF
#5986Methods of treatment
#5987METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS
#5988PHARMACEUTICAL COMPOSITION CONTAINING ILAPRAZOLE OR SALT THEREOF AND PREPARATION METHOD THEREFOR
#5989COMBINED THERAPY WITH ICOS BINDING PROTEINS AND ARGININEMETHYLTRANSFERASE INHIBITORS
#5990Envenomation therapies and related pharmaceutical compositions, systems and kits
#5991AZELAIC ACID ESTERS IN THE TREATMENT OF INSULIN RESISTANCE
#5992Materials and methods for controlling infections
#5993THROMBOLYTIC MICROSPHERES TO DISSOLVE VASO-OCCLUSIVE CLOTS
#5994TREATMENT OF SEPSIS AND SEPTIC SHOCK
#5995FORMULATION CONTAINING EMRICASAN
#5996Treatment of epithelial cysts by intracystic injection of antineoplastic particles
#5997Stable pharmaceutical composition comprising testosterone undecanoate
#5998Compositions and uses of alpha-adrenergic agents
#5999Compositions and uses of alpha-adrenergic agents
#6000DEVICES AND METHODS TO TREAT AND PREVENT DIVERTICULITIS